Radiotherapy of high-grade gliomas: first half of 2021 update with special reference to radiosensitization studies
G Frosina - International Journal of Molecular Sciences, 2021 - mdpi.com
Albeit the effort to develop targeted therapies for patients with high-grade gliomas (WHO
grades III and IV) is evidenced by hundreds of current clinical trials, radiation remains one of …
grades III and IV) is evidenced by hundreds of current clinical trials, radiation remains one of …
Sex-Specific Differences in Patients with IDH1–Wild-Type Grade 4 Glioma in the ReSPOND Consortium
BACKGROUND AND PURPOSE: Understanding sex-based differences in patients with
glioblastoma is necessary for accurate personalized treatment planning to improve patient …
glioblastoma is necessary for accurate personalized treatment planning to improve patient …
Sex-specific Differences in IDH1-Wildtype Glioblastoma patients in the ReSPOND Consortium
S Gongala, JA Garcia, N Korakavi… - American Journal …, 2024 - Am Soc Neuroradiology
Background: Understanding sex-based differences in glioblastoma patients is necessary for
accurate personalized treatment planning to improve patient outcomes. Purpose: To …
accurate personalized treatment planning to improve patient outcomes. Purpose: To …
Patient‐specific radiological protection precautions following Cs collagen embedded Cs‐131 implantation in the brain
K Prasad, LT Dauer, BP Chu… - Journal of Applied …, 2022 - Wiley Online Library
Objective Cesium‐131 brachytherapy is an adjunct for brain tumor treatment, offering
potential clinical and radiation protection advantages over other isotopes including iodine …
potential clinical and radiation protection advantages over other isotopes including iodine …
Brachytherapy
Radiation therapy is a cornerstone in the treatment of central nervous system (CNS) tumors,
with brachytherapy offering a unique and advantageous approach by placing localized …
with brachytherapy offering a unique and advantageous approach by placing localized …
[HTML][HTML] Dosimetric Impact of Source Displacement in GammaTile Surgically Targeted Radiation Therapy for Gliomas
SK Ng, Y Yue, K Shiue, MV Shah, Y Le - Cureus, 2023 - ncbi.nlm.nih.gov
Background This study aims to evaluate dosimetric changes that happened during the first
month after GammaTile surgically targeted radiation therapy (STaRT) for gliomas due to …
month after GammaTile surgically targeted radiation therapy (STaRT) for gliomas due to …